4/A//SEC Filing
OSIRIS THERAPEUTICS, INC. 4/A
Accession 0001179110-16-021614
CIK 0001360886operating
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 6:53 AM ET
Size
5.5 KB
Accession
0001179110-16-021614
Insider Transaction Report
Form 4/AAmended
Montgomery Bobby Dwayne
Chief Business Officer
Transactions
- Award
Incentive Stock Option (right to buy)
2016-03-04$7.39/sh+10,000$73,900→ 47,500 totalExercise: $7.39From: 2017-03-04Exp: 2026-03-04→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Options to purchase 10,000 shares of the common stock of the Registrant shall become exercisable with respect to the underlying shares as to 25% on each March 4, 2017, 2018, 2019, 2020, assuming the Reporting Person continues to be employed by the Registrant on the vesting date.
Documents
Issuer
OSIRIS THERAPEUTICS, INC.
CIK 0001360886
Entity typeoperating
IncorporatedMD
Related Parties
1- filerCIK 0001360886
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 6:53 AM ET
- Size
- 5.5 KB